These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Research and development strategies, examples among new vaccines]. Denis F; Ploy MC Ann Pharm Fr; 2009 May; 67(3):198-202. PubMed ID: 19446670 [TBL] [Abstract][Full Text] [Related]
4. [A new process of inactivation for preparation of vaccines]. Relyveld EH; Girard O; Cheyroux M; Asso J; de Rudder J Dev Biol Stand; 1974; 27():236-48. PubMed ID: 4218994 [No Abstract] [Full Text] [Related]
5. Two meanings of reverse vaccinology and the empirical nature of vaccine science. Van Regenmortel MH Vaccine; 2011 Oct; 29(45):7875. PubMed ID: 21888936 [No Abstract] [Full Text] [Related]
6. Strategies of constructing recombinant vaccines. Sałamaszyńska-Guz A; Klimuszko D Pol J Vet Sci; 2009; 12(1):133-9. PubMed ID: 19459451 [TBL] [Abstract][Full Text] [Related]
7. [Advances in the study of genetic engineering vaccine delivered by probiotics]. Wang C; Zhang C Wei Sheng Yan Jiu; 2008 Jan; 37(1):118-22. PubMed ID: 18421883 [TBL] [Abstract][Full Text] [Related]
8. [Trends in the studies of the preparations of active and passive immunization. Bacterial vaccines]. Gałazka A Przegl Epidemiol; 1988; 42(4):317-31. PubMed ID: 3247475 [No Abstract] [Full Text] [Related]
9. [Molecular biology of paramyxoviruses and its significance for the development of vaccines]. Scheid A Internist (Berl); 1985 Feb; 26(2):98-102. PubMed ID: 3884533 [No Abstract] [Full Text] [Related]
10. Molecular approaches for safer and stronger vaccines. Del Giudice G; Rappuoli R Schweiz Med Wochenschr; 1999 Nov; 129(46):1744-8. PubMed ID: 10603647 [TBL] [Abstract][Full Text] [Related]
11. Engineering attenuated virus vaccines by controlling replication fidelity. Vignuzzi M; Wendt E; Andino R Nat Med; 2008 Feb; 14(2):154-61. PubMed ID: 18246077 [TBL] [Abstract][Full Text] [Related]
12. Genetically engineered vaccines: problems and promises. Brown F; Dougan G; Snary D Microbiol Sci; 1984 Aug; 1(5):123-7. PubMed ID: 6444113 [TBL] [Abstract][Full Text] [Related]
14. Formulation, stability, and delivery of live attenuated vaccines for human use. Burke CJ; Hsu TA; Volkin DB Crit Rev Ther Drug Carrier Syst; 1999; 16(1):1-83. PubMed ID: 10099898 [TBL] [Abstract][Full Text] [Related]
15. [Contemporary vaccinology--scientific and practical aspects]. Piotrowska-Jastrzebska J; Mikołuć B; Motkowski R Pol Merkur Lekarski; 2002 Jun; 12(72):526-9. PubMed ID: 12362676 [TBL] [Abstract][Full Text] [Related]